BioMarin Pharmaceutical Inc.
US ˙ NasdaqGS ˙ US09061G1013

SecurityBMRN / BioMarin Pharmaceutical Inc.
InstitutionONEQ - Fidelity Nasdaq Composite Index Tracking Stock
Latest Disclosed Ownership45,167 shares
Latest Disclosed Value $ 2,622,847
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock reports 0.49% increase in ownership of BMRN / BioMarin Pharmaceutical Inc.

On July 24, 2025 - ONEQ - Fidelity Nasdaq Composite Index Tracking Stock filed a NPORT-P form disclosing ownership of 45,167 shares of BioMarin Pharmaceutical Inc. (US:BMRN) valued at $2,622,848 USD as of May 31, 2025. The entity filed a previous NPORT-P on April 25, 2025 disclosing 44,947 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 0.49% during the quarter. The current value of the position is $2,564,131 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-07-24 2025-05-31 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 45,167 220 0.49 2,623 -18.01 0.0347
2025-04-25 2025-02-28 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 44,947 -575 -1.26 3,198 6.42 0.0431
2025-01-27 2024-11-30 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 45,522 322 0.71 3,006 -27.10 0.0408
2024-10-29 2024-08-31 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 45,200 437 0.98 4,123 22.68 0.0611
2024-07-26 2024-05-31 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 44,763 575 1.30 3,360 -11.86 0.0532
2024-04-24 2024-02-29 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 44,188 713 1.64 3,813 -3.71 0.0637
2024-01-24 2023-11-30 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 43,475 69 0.16 3,960 -0.18 0.0759
2023-10-27 2023-08-31 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 43,406 690 1.62 3,966 6.81 0.0775
2023-07-26 2023-05-31 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 42,716 138 0.32 3,714 -12.43 0.0801
2023-04-27 2023-02-28 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 42,578 1,035 2.49 4,240 1.07 0.1037
2023-01-26 2022-11-30 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 41,543 1,081 2.67 4,195 16.24 0.1049
2022-10-26 2022-08-31 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 40,462 1,107 2.81 3,609 22.09 0.0903
2022-07-29 2022-05-31 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 39,355 1,196 3.13 2,957 -0.81 0.0753
2022-04-28 2022-02-28 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 38,159 598 1.59 2,981 -8.05 0.0691
2022-01-25 2021-11-30 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 37,561 989 2.70 3,241 5.26 0.0677
2021-10-26 2021-08-31 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 36,572 759 2.12 3,080 11.24 0.0675
2021-07-22 2021-05-31 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 35,813 126 0.35 2,768 0.18 0.0688
2021-04-23 2021-02-28 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 35,687 24,696 224.69 2,763 219.79 0.0720
2021-01-20 2020-11-30 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 10,991 -22,689 -67.37 865 -67.12 0.0259
2020-10-16 2020-08-31 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 33,680 611 1.85 2,628 -25.40 0.0811
2020-07-20 2020-05-31 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 33,069 588 1.81 3,524 20.03 0.1376
2020-04-24 2020-02-29 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 32,481 6,178 23.49 2,935 38.31 0.1310
2020-01-16 2019-11-30 NP BIOMARIN PHARMACEUTICAL EC US09061G1013 26,303 26,303 2,123 0.0964
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.